Hiroyuki Aono

3.4k total citations
91 papers, 2.6k citations indexed

About

Hiroyuki Aono is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Hiroyuki Aono has authored 91 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 19 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in Hiroyuki Aono's work include Spine and Intervertebral Disc Pathology (17 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Spinal Fractures and Fixation Techniques (11 papers). Hiroyuki Aono is often cited by papers focused on Spine and Intervertebral Disc Pathology (17 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Spinal Fractures and Fixation Techniques (11 papers). Hiroyuki Aono collaborates with scholars based in Japan, United States and Netherlands. Hiroyuki Aono's co-authors include Tomoko Hasunuma, Motoki Iwasaki, Fumio Tsuji, Shinya Okuda, Kazuhiko Yamamoto, Kusuki Nishioka, Takeshi Fuji, Koushi Fujisawa, Tetsuo Ohwada and Shota Takenaka and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Radiology.

In The Last Decade

Hiroyuki Aono

89 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Aono Japan 27 702 660 636 583 474 91 2.6k
Satoru Kikuchi Japan 30 780 1.1× 785 1.2× 338 0.5× 357 0.6× 88 0.2× 153 2.8k
Aritoshi Iida Japan 33 2.1k 3.0× 643 1.0× 278 0.4× 720 1.2× 532 1.1× 126 4.5k
Robert Shenkar United States 40 1.4k 2.0× 327 0.5× 219 0.3× 1.3k 2.2× 168 0.4× 90 5.2k
Hans‐Peter Fischer Germany 36 816 1.2× 704 1.1× 385 0.6× 314 0.5× 156 0.3× 137 3.6k
Eishin Yaoita Japan 36 2.4k 3.4× 457 0.7× 188 0.3× 460 0.8× 191 0.4× 117 4.2k
Serena M. Bagnasco United States 39 1.2k 1.7× 921 1.4× 192 0.3× 505 0.9× 142 0.3× 90 3.9k
Toshiyuki Yamada Japan 31 2.2k 3.1× 401 0.6× 195 0.3× 673 1.2× 127 0.3× 138 4.6k
Shuji Bandoh Japan 29 530 0.8× 210 0.3× 234 0.4× 218 0.4× 214 0.5× 115 2.4k
Edoardo Alesse Italy 37 1.9k 2.7× 238 0.4× 376 0.6× 796 1.4× 164 0.3× 126 4.2k
Igor Buchwalow Germany 27 1.1k 1.6× 316 0.5× 254 0.4× 530 0.9× 76 0.2× 126 2.7k

Countries citing papers authored by Hiroyuki Aono

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Aono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Aono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Aono more than expected).

Fields of papers citing papers by Hiroyuki Aono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Aono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Aono. The network helps show where Hiroyuki Aono may publish in the future.

Co-authorship network of co-authors of Hiroyuki Aono

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Aono. A scholar is included among the top collaborators of Hiroyuki Aono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Aono. Hiroyuki Aono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Takenaka, Shota & Hiroyuki Aono. (2016). Prediction of Postoperative Clinical Recovery of Drop Foot Attributable to Lumbar Degenerative Diseases, via a Bayesian Network. Clinical Orthopaedics and Related Research. 475(3). 872–880. 31 indexed citations
3.
Tsuji, Fumio, et al.. (2012). Bucillamine inhibits CD40-mediated Akt activation and antibody production in mouse B‐cell lymphoma. International Immunopharmacology. 14(1). 47–53.
4.
Oda, Tomoko, et al.. (2011). Beneficial Pharmacological Effects of Selective Glucocorticoid Receptor Agonist in External Eye Diseases. Journal of Ocular Pharmacology and Therapeutics. 27(4). 353–360. 19 indexed citations
5.
Tsuji, Fumio, Taeko Hata, Minoru Narita, et al.. (2011). The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain. European Journal of Pharmacology. 671(1-3). 53–60. 10 indexed citations
6.
Tsuji, Fumio, Masaaki Murai, Kenji Oki, et al.. (2010). Effects of SA13353, a Transient Receptor Potential Vanilloid 1 Agonist, on Leukocyte Infiltration in Lipopolysaccharide-Induced Acute Lung Injury and Ovalbumin-Induced Allergic Airway Inflammation. Journal of Pharmacological Sciences. 112(4). 487–490. 20 indexed citations
7.
Sato, Tomoo, Ryoji Fujii, Hiroyuki Aono, et al.. (2010). Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes. Annals of the Rheumatic Diseases. 70(1). 221–226. 24 indexed citations
8.
Kawashima, Kenji, Minoru Yamamoto, Kazuyoshi Okamoto, et al.. (2010). Pyridylmethylthio derivatives as VEGF inhibitors. Part 1. Bioorganic & Medicinal Chemistry Letters. 20(24). 7234–7238. 10 indexed citations
9.
Aono, Hiroyuki, et al.. (2008). Synthesis of novel 1,4-benzoxazin-3-one derivatives as inhibitors against tyrosine kinases. Bioorganic & Medicinal Chemistry. 17(2). 699–708. 12 indexed citations
11.
Kaneko, Yasushi, et al.. (2008). Conformation–activity relationship on novel 4-pyridylmethylthio derivatives with antiangiogenic activity. Bioorganic & Medicinal Chemistry Letters. 18(9). 2939–2943. 17 indexed citations
12.
Tsuji, Fumio, et al.. (2007). Bucillamine mechanism inhibiting IL-1β-induced VEGF production from fibroblast-like synoviocytes. International Immunopharmacology. 7(12). 1569–1576. 14 indexed citations
13.
Aono, Hiroyuki, Motoki Iwasaki, Tetsuo Ohwada, et al.. (2007). Surgical Outcome of Drop Foot Caused by Degenerative Lumbar Diseases. Spine. 32(8). E262–E266. 75 indexed citations
14.
Nakazawa, Minako, Hiroyuki Aono, Satoko Aratani, et al.. (2001). Role of notch-1 intracellular domain in activation of rheumatoid synoviocytes. Arthritis & Rheumatism. 44(7). 1545–1554. 54 indexed citations
15.
Aono, Hiroyuki, Koushi Fujisawa, Tomoko Hasunuma, Susan J. Marriott, & Kusuki Nishioka. (1998). Extracellular human T cell leukemia virus type I tax protein stimulates the proliferation of human synovial cells. Arthritis & Rheumatism. 41(11). 1995–2003. 17 indexed citations
16.
Hasunuma, Tomoko, Ulf Müller‐Ladner, Hiroyuki Aono, et al.. (1997). Tenosynovial nodulosis in a patient infected with human T cell lymphotropic virus I. Arthritis & Rheumatism. 40(3). 578–582. 2 indexed citations
17.
Hasunuma, Tomoko, Hiroyuki Aono, Hiroshi Asahara, et al.. (1996). Induction of Fas-dependent apoptosis in synovial infiltrating cells in rheumatoid arthritis. International Immunology. 8(10). 1595–1602. 25 indexed citations
18.
Fujisawa, Koushi, Hiroyuki Aono, Tomoko Hasunuma, et al.. (1996). Activation of transcription factor NF‐κB in human synovial cells in response to tumor necrosis factor α. Arthritis & Rheumatism. 39(2). 197–203. 126 indexed citations
19.
Yamamoto, Kazuhiko, Hiroyuki Aono, Takeshi Nakajima, Tomoko Hasunuma, & K Nishioka. (1995). Oligoclonal Proliferation of Human T-Cell Leukemia Virus Type I Infected Lymphocytes in Lesions of Virus-Induced Arthropathy. Biochemical and Biophysical Research Communications. 208(3). 1040–1045. 10 indexed citations
20.
Hasunuma, Tomoko, Toshihiro Nakajima, Hiroyuki Aono, et al.. (1994). Establishment and Characterization of Synovial Cell Clones with Integrated Human T-Cell Leukemia Virus Type-I. Clinical Immunology and Immunopathology. 72(1). 90–97. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026